{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:16:41Z","timestamp":1772770601581,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20397, 81873302, 81704081"],"award-info":[{"award-number":["U20A20397, 81873302, 81704081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2017B030314166 , 2020B1111100005"],"award-info":[{"award-number":["2017B030314166 , 2020B1111100005"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Metabolic status and gut microecology are implicated in psoriasis. Methotrexate (MTX) is usually the first-line treatment for this disease. However, the relationship between MTX and host metabolic status and the gut microbiota is unclear. This study aimed to characterize the features of blood metabolome and gut microbiome in patients with psoriasis after treatment with MTX. Serum and stool samples were collected from 15 patients with psoriasis. Untargeted liquid chromatography\u2013mass spectrometry and metagenomics sequencing were applied to profile the blood metabolome and gut microbiome, respectively. We found that the response to MTX varied according to metabolomic and metagenomic features at baseline; for example, patients who had high levels of serum nutrient molecular and more enriched gut microbiota had a poor response. After 16 weeks of MTX, we observed a reduction in microbial activity pathways, and patients with a good response showed more microbial activity and less biosynthesis of serum fatty acid. We also found an association between the serum metabolome and the gut microbiome before intervention with MTX. Carbohydrate metabolism, transporter systems, and protein synthesis within microbes were associated with host metabolic clusters of lipids, benzenoids, and organic acids. These findings suggest that the metabolic status of the blood and the gut microbiome is involved in the effectiveness of MTX in psoriasis, and that inhibition of symbiotic intestinal microbiota may be one of the mechanisms of action of MTX. Prospective studies in larger sample sizes are needed to confirm these findings.<\/jats:p>","DOI":"10.3389\/fimmu.2022.937539","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T13:47:58Z","timestamp":1662558478000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasis"],"prefix":"10.3389","volume":"13","author":[{"given":"Qinwei","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danni","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusheng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangjuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runyue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanjian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00788","article-title":"Metabolic syndrome and skin diseases","volume":"10","author":"Hu","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000455840","article-title":"Psoriasis and obesity","volume":"232","author":"Jensen","year":"2016","journal-title":"Dermatology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001242","article-title":"Research progress and perspective in metabolism and metabolomics of psoriasis","volume":"133","author":"Lian","year":"2020","journal-title":"Chin Med J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17349","article-title":"Glucose metabolism in patients with psoriasis","volume":"180","author":"Friis","year":"2019","journal-title":"Br J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15008","article-title":"Exploration of candidate biomarkers for human psoriasis based on gas chromatography-mass spectrometry serum metabolomics","volume":"176","author":"Kang","year":"2017","journal-title":"Br J Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1021\/pr500782g","article-title":"LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNF\u03b1 treatment","volume":"14","author":"Kamleh","year":"2015","journal-title":"J Proteome Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.12688\/f1000research.4709.1","article-title":"Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis","volume":"3","author":"Armstrong","year":"2014","journal-title":"F1000Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.02.003","article-title":"Bioactive lipid mediator profiles in human psoriasis skin and blood","volume":"138","author":"Sorokin","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10885.x","article-title":"Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair","volume":"166","author":"de Koning","year":"2012","journal-title":"Br J Dermatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-13-8","article-title":"Metabolic changes in psoriatic skin under topical corticosteroid treatment","volume":"13","author":"Sitter","year":"2013","journal-title":"BMC Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix087","article-title":"Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis","volume":"6","author":"Zeng","year":"2017","journal-title":"Gigascience"},{"key":"B14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3390\/cells9020511","article-title":"(R)-salbutamol improves imiquimod-induced psoriasis-like skin dermatitis by regulating the Th17\/Tregs balance and glycerophospholipid metabolism","volume":"9","author":"Liu","year":"2020","journal-title":"Cells"},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-018-0220-0","article-title":"Effects of daily consumption of the probiotic bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial","volume":"43","author":"Pedret","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.09.055","article-title":"Microbially produced imidazole propionate impairs insulin signaling through mTORC1","volume":"175","author":"Koh","year":"2018","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/pathogens9060463","article-title":"Gut microbiome in psoriasis: An updated review","volume":"9","author":"Sikora","year":"2020","journal-title":"Pathogens"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20205023","article-title":"Methotrexate an old drug with new tricks","volume":"20","author":"Bedoui","year":"2019","journal-title":"IJMS"},{"key":"B20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13075-018-1729-2","article-title":"Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology","volume":"20","author":"Teitsma","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.12.008","article-title":"Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation","volume":"29","author":"Nayak","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/art.41622","article-title":"The pretreatment gut microbiome is associated with lack of response to methotrexate in new-onset rheumatoid arthritis","volume":"73","author":"Artacho","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-018-0064-z","article-title":"A computational framework to integrate high-throughput \u2018-omics\u2019 datasets for the identification of potential mechanistic links","volume":"13","author":"Pedersen","year":"2018","journal-title":"Nat Protoc"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix120","article-title":"SOAPnuke: a MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data","volume":"7","author":"Chen","year":"2018","journal-title":"Gigascience"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp336","article-title":"SOAP2: an improved ultrafast tool for short read alignment","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3589","article-title":"MetaPhlAn2 for enhanced metagenomic taxonomic profiling","volume":"12","author":"Truong","year":"2015","journal-title":"Nat Methods"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-018-0176-y","article-title":"Species-level functional profiling of metagenomes and metatranscriptomes","volume":"15","author":"Franzosa","year":"2018","journal-title":"Nat Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2011.335","article-title":"Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry","volume":"6","author":"Dunn","year":"2011","journal-title":"Nat Protoc"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1021\/ac500317c","article-title":"Objective set of criteria for optimization of sample preparation procedures for ultra-high throughput untargeted blood plasma lipid profiling by ultra performance liquid chromatography-mass spectrometry","volume":"86","author":"Sarafian","year":"2014","journal-title":"Anal Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11306-016-1030-9","article-title":"Non-targeted UHPLC-MS metabolomic data processing methods: a comparative investigation of normalisation, missing value imputation, transformation and scaling","volume":"12","author":"Di Guida","year":"2016","journal-title":"Metabolomics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an r package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baaa055","article-title":"CNSA: a data repository for archiving omics data","volume":"2020","author":"Guo","year":"2020","journal-title":"Database"},{"key":"B34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.16288\/j.yczz.20-080","article-title":"CNGBdb: China national GeneBank DataBase","volume":"42","author":"Chen","year":"2020","journal-title":"Yi Chuan"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.003351","article-title":"PROMIS, global analysis of PROtein-metabolite interactions using size separation in arabidopsis thaliana","volume":"293","author":"Veyel","year":"2018","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24393","article-title":"Pharmacokinetic interaction between methotrexate and chloral hydrate","volume":"60","author":"Dao","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.11.002","article-title":"NAD+ intermediates: The biology and therapeutic potential of NMN and NR","volume":"27","author":"Yoshino","year":"2018","journal-title":"Cell Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-7156-3_4","article-title":"The natural polyamines and the immune system","volume":"43","author":"Seiler","year":"1994","journal-title":"Prog Drug Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.21245","article-title":"Patients with psoriasis have a dysbiotic taxonomic and functional gut microbiota","volume":"187","author":"Todberg","year":"2022","journal-title":"Br J Dermatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12866-021-02125-1","article-title":"Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Microbiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.605825","article-title":"Deciphering gut microbiota dysbiosis and corresponding genetic and metabolic dysregulation in psoriasis patients using metagenomics sequencing","volume":"11","author":"Xiao","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094529","article-title":"Psoriasis and gut microbiome-current state of art","volume":"22","author":"Polak","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.7","article-title":"Dysbiosis and the immune system","volume":"17","author":"Levy","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323071","article-title":"Gut microbiota-derived metabolites as central regulators in metabolic disorders","volume":"70","author":"Agus","year":"2021","journal-title":"Gut"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","author":"Krautkramer","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1126\/science.1223813","article-title":"Host-gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2018.1425672","article-title":"On the intrinsic constraint of bacterial growth rate: M. tuberculosis\u2019s view of the protein translation capacity","volume":"44","author":"Zhu","year":"2018","journal-title":"Crit Rev Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.937539\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T13:48:09Z","timestamp":1662558489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.937539\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2022.937539"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.937539","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"article-number":"937539"}}